Biological Alzheimer’s disease is characterized by a preclinical period lasting over a decade in which detectable amyloid-β and tau accumulate in the absence of cognitive symptoms; in familial Alzheimer’s disease, plasma phosphorylated tau concentration starts to increase around 15 years prior to expected clinical disease onset.8 The gene discussed is MAPT; the disease is Alzheimer disease.